CDKN2A and central nervous system cancer: The results revealed that compared to high‐grade gliomas, low‐grade gliomas exhibited a significantly increased proportion of HIP1R+ tumor cells, while the proportions of ATRX+ and CDKN2A+ tumor cells showed no significant differences across grades (Figure 2B, left).